Trials by Condition

Showing 1 - 6 of 6 trials – Showing only trials currently accepting patients

• Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)

  Stanford is currently accepting patients for this trial.

• Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

  Stanford is currently accepting patients for this trial.

• Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

  Stanford is currently accepting patients for this trial.

• Early Intervention in Cystic Fibrosis Exacerbation

  Stanford is currently accepting patients for this trial.

• Infant Study of Inhaled Saline in Cystic Fibrosis

  Stanford is currently accepting patients for this trial.

• A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

  Stanford is currently accepting patients for this trial.